A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%

A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%

The objective of this study is to identify any adverse events or adverse drug reactions through post-marketing surveillance under routine clinical practice

The objective of this study is to identify any adverse events or adverse drug reactions through post-marketing surveillance under routine clinical practice after marketing authorization of Lotemax ophthalmic suspension 0.5%

Inclusion Criteria:

• Subjects who have been treated with the study drug at least once and completed safety follow-up.
• Subjects who have been treated with the study drug at least once and completed the clinical efficacy assessment.

Exclusion Criteria:

• Subjects not treated with study drug at least once.